GITHAHO BIOCLIN: what changed
What changed
GITHAHO BIOCLIN
NACE 86.910, Medical imaging and medical laboratories
filed annual accounts (NBB)
Net result for the year
€253,688
2024 · €305,124-€51,437
Equity
€854,884
2024 · €751,196+€103,688
Cash
€300,978
2024 · €203,496+€97,482
Balance sheet total
€1.0m
2024 · €926,918+€104,822
Largest movements
Assets
- Cash +€97,482
up €97,482 (+47.9%), from €203,496 to €300,978
mainly Net result for the year (+€253,688) and Deferred charges and accrued income (+€66,433)
- Deferred charges and accrued income -€66,433
down €66,433 (-23.9%), from €277,887 to €211,454
- Current investments +€60,000
up €60,000 (+13.6%), from €441,666 to €501,666
- Receivables within one year +€14,707
up €14,707 (+1,126%), from €1,306 to €16,013
Equity and liabilities
- Profit (loss) carried forward +€103,688
up €103,688 (+14.2%), from €730,736 to €834,424
Income statement
- Turnover -€69,782
down €69,782 (-14.3%), from €487,065 to €417,283
- Gross operating margin -€69,447
down €69,447 (-17.1%), from €406,160 to €336,713
- Taxes -€17,194
down €17,194 (-17.9%), from €96,181 to €78,987
- Purchases and services +€8,084
up €8,084 (+9.3%), from €86,808 to €94,891
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€305,124
Gross operating margin
-€69,447
Depreciation
-€11
Other operating charges
+€746
Financial income
+€1
Financial charges
+€80
Taxes
+€17,194
Result 2025
€253,688
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€307,482
Investment
-€60,000
Financing
-€150,000
Cash 2024
€203,496
From operations (derived)
+€307,482
Net result for the year
+€253,688
Depreciation
+€935
Receivables within one year
-€14,707
Deferred charges and accrued income
+€66,433
Trade debts
-€41
Other debts
+€1,175
Investment (derived)
-€60,000
Current investments
-€60,000
Financing
-€150,000
Contributions, distributions and other
-€150,000
Cash 2025
€300,978
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €926,918 | €1,031,739 | +€104,822 | +11.3% |
| Formation expenses | 20 | €631 | €397 | -€234 | -37.1% |
| Fixed assets | 21/28 | €1,932 | €1,231 | -€701 | -36.3% |
| Tangible fixed assets | 22/27 | €1,932 | €1,231 | -€701 | -36.3% |
| Plant, machinery and equipment | 23 | €142 | €0 | -€142 | -100% |
| Furniture and vehicles | 24 | €1,790 | €1,231 | -€559 | -31.2% |
| Current assets | 29/58 | €924,355 | €1,030,111 | +€105,756 | +11.4% |
| Amounts receivable within one year | 40/41 | €1,306 | €16,013 | +€14,707 | +1,126% |
| Other amounts receivable | 41 | €1,306 | €16,013 | +€14,707 | +1,126% |
| Current investments | 50/53 | €441,666 | €501,666 | +€60,000 | +13.6% |
| Cash at bank and in hand | 54/58 | €203,496 | €300,978 | +€97,482 | +47.9% |
| Deferred charges and accrued income | 490/1 | €277,887 | €211,454 | -€66,433 | -23.9% |
| Total equity and liabilities | 10/49 | €926,918 | €1,031,739 | +€104,822 | +11.3% |
| Equity | 10/15 | €751,196 | €854,884 | +€103,688 | +13.8% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €730,736 | €834,424 | +€103,688 | +14.2% |
| Amounts payable | 17/49 | €175,721 | €176,855 | +€1,134 | +0.6% |
| Amounts payable within one year | 42/48 | €175,721 | €176,855 | +€1,134 | +0.6% |
| Trade debts | 44 | €84 | €43 | -€41 | -49.3% |
| Suppliers | 440/4 | €84 | €43 | -€41 | -49.3% |
| Taxes, remuneration and social security | 45 | €43,681 | €43,681 | = | 0.0% |
| Taxes | 450/3 | €43,681 | €43,681 | = | 0.0% |
| Remuneration and social security | 454/9 | €0 | €0 | = | |
| Other amounts payable | 47/48 | €131,956 | €133,131 | +€1,175 | +0.9% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Turnover | 70 | €487,065 | €417,283 | -€69,782 | -14.3% |
| Goods, raw materials, services and sundry goods | 60/61 | €86,808 | €94,891 | +€8,084 | +9.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €924 | €935 | +€11 | +1.2% |
| Other operating charges | 640/8 | €1,043 | €298 | -€746 | -71.5% |
| Gross operating margin | 9900 | €406,160 | €336,713 | -€69,447 | -17.1% |
| Operating profit (loss) | 9901 | €404,193 | €335,481 | -€68,712 | -17.0% |
| Financial income | 75/76B | - | €1 | +€1 | |
| Recurring financial income | 75 | - | €1 | +€1 | |
| Financial charges | 65/66B | €2,887 | €2,807 | -€80 | -2.8% |
| Recurring financial charges | 65 | €2,887 | €2,807 | -€80 | -2.8% |
| Profit (loss) for the period before taxes | 9903 | €401,306 | €332,675 | -€68,631 | -17.1% |
| Income taxes | 67/77 | €96,181 | €78,987 | -€17,194 | -17.9% |
| Profit (loss) for the period | 9904 | €305,124 | €253,688 | -€51,437 | -16.9% |
| Profit (loss) for the period to be appropriated | 9905 | €305,124 | €253,688 | -€51,437 | -16.9% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.